Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL576793 | 1.00 | SOS1 (0.34) | SOS1SOS2 | |
| SCHEMBL1907294 | 0.87 | SOS1 (0.30) | SOS1SOS2 | |
| Ammonia Solution, Strong SCHEMBL28132440 | 0.85 | — | — | |
| SCHEMBL8005344 | 0.85 | — | — | |
| SCHEMBL457018 | 0.83 | CXCR4 (0.36) | — | |
| SCHEMBL28213926 | 0.78 | — | — | |
| SCHEMBL9241450 | 0.78 | SOS1 (0.33) | SOS1SOS2 | |
| Formamide SCHEMBL29115926 | 0.77 | — | — | |
| SCHEMBL28144701 | 0.76 | CXCR4 (0.32) | — | |
| SCHEMBL8219562 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3383441-A1 | FORMULATIONS COMPRISING A COMBINATION OF MRI CONTRAST AGENTS | GE Healthcare AS (NO) | 2018-10-10 | — | — | EP | claimed |
| WO-2017093336-A1 | FORMULATIONS COMPRISING A COMBINATION OF MRI CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2017-06-08 | — | — | WO | claimed |
| EP-2661473-A1 | ANTISKINNING COMPOSITIONS | OMG UK Technology Limited (GB) | 2013-11-13 | — | — | EP | claimed |
| WO-2012093250-A1 | ANTISKINNING COMPOSITIONS | OMG ADDITIVES LIMITED (GB) | 2012-07-12 | — | — | WO | claimed |
| EP-0998466-A1 | A PROCESS FOR THE PREPARATION OF TETRAAZAMACROCYCLES | BRACCO IMAGING S.p.A. (IT) | 2000-05-10 | — | — | EP | claimed |
| WO-1999005128-A1 | A PROCESS FOR THE PREPARATION OF TETRAAZAMACROCYCLES | BRACCO S.P.A. (IT) | 1999-02-04 | — | — | WO | claimed |
| CN-114555132-A | Method for producing radiometal-labeled antibody | 日本医事物理股份有限公司 | 2022-05-27 | — | — | CN | disclosed |
| EP-2279190-A1 | COMPOUNDS COMPRISING PARAMAGNETIC CHELATES ARRANGED AROUND A CENTRAL CORE AND THEIR USE IN MAGNETO RESONANCE IMAGING AND SPECTROSCOPY | GE HEALTHCARE AS (NO) | 2011-02-02 | — | — | EP | disclosed |
| WO-2009127715-A1 | COMPOUNDS COMPRISING PARAMAGNETIC CHELATES ARRANGED AROUND A CENTRAL CORE AND THEIR USE IN MAGNETO RESONANCE IMAGING AND SPECTROSCOPY | GE HEALTHCARE AS (NO) | 2009-10-22 | — | — | WO | disclosed |
| EP-1960393-A1 | MULTIMERIC MAGENTIC RESONANCE CONTRAST AGENTS | GE Healthcare AS (NO) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007111514-A1 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY CONSISTING OF A CYCLIC OLIGOAMID CORE OF 3 TO 4 IDENTICAL MONOMER UNITS WITH 3 TO 4 PARAMAGNETIC CHELATE SIDE CHAINS | GE HEALTHCARE AS (NO) | 2007-10-04 | — | — | WO | disclosed |
| WO-2007064227-A1 | MULTIMERIC MAGENTIC RESONANCE CONTRAST AGENTS | GE HEALTHCARE AS (NO) | 2007-06-07 | — | — | WO | disclosed |
| US-7164016-B2 | Macrocyclic metal complexes and their use for the production of conjugates with biomolecules | SCHERING AG (DE) | 2007-01-16 | — | — | US | disclosed |
| US-20030108486-A1 | Macrocyclic metal complexes and their use for the production of conjugates with biomolecules | SCHERING AG (DE) | 2003-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030108486-A1 | Macrocyclic metal complexes and their use for the production of conjugates with biomolecules | CA13, MPI, CA14 | SOS1 4823/4885SOS2 4792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.